Neslihan Duzkale1,*, Hikmet Taner Teker2
Oncologie, Vol.22, No.2, pp. 65-74, 2020, DOI:10.32604/oncologie.2020.013707
Abstract BRCA1/2 genes are responsible for the hereditary breast and ovarian
cancer syndrome. In this study, Turkish women with ovarian cancer were
investigated in terms of demographic, clinicopathologic and family cancer stories
according to their condition of the BRCA1/2 genes mutation carrier. During 2011
to 2017 in Turkey, BRCA1 and BRCA2 genes were analyzed in 38 women, who
were diagnosed with cancer using Next Generation Sequencing technique.
Pathogenic mutations were detected in 9 (23.7%) of patients. The diagnosis age
for Ovarian cancer patients for BRCA1/2 mutation carriers was found higher. It
was seen that mutations mostly occurred in the… More >